APLM · Apollomics Inc.
$23.55
+0.15 (+0.64%)
At close · Aug 17
Market Cap
$51.39M
Shares
2.20M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$23.55
Open$22.96
Day$22.33–25.50
52W close$3.93–36.65
Avg vol 30d36K
Short int7K · 0.3% float · 1.0d
Short vol50%
Last earningsDec 31, 2023
DataNov 2024–Aug 2026
Raw chart and full-history price indicators begin at the captured split on Nov 25, 2024; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Very Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
Golden cross
Price vs 200-day avg
+35%
above
Price vs 50-day avg
+31%
above
RSI (14)
68
neutral
MACD trend
Positive
52-week position
60%
mid-range
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+27%
trailing
6-month return
+16%
trailing
YTD return
+26%
this year
Relative strength
+2%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Golden cross
50d $18 › 200d $17 — 50d above 200d
Institutional flow
Accumulating
+275% holders QoQ · +12 funds added
Insider flow
Accumulating
Net +$8.3M over 90 days · 0% sells
Short interest
Falling
0.31% of float · ▼ -32.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 3-yr range
Squeeze score
35
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
162%
annualized · 1-yr
Max drawdown
−68%
past year
ATR
7.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
Golden cross
Bullish
Price vs 200-day avg
+35%
Bullish
Price vs 50-day avg
+31%
Bullish
RSI (14)
68
Neutral
MACD trend
Positive
Bullish
52-week position
60%
Neutral
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bullish · 4 of 6
Trend (MA cross)
Golden cross
50d $18 › 200d $17 — 50d above 200d
Institutional flow
Accumulating
+275% holders QoQ · +12 funds added
Insider flow
Accumulating
Net +$8.3M over 90 days · 0% sells
Short interest
Falling
0.31% of float · ▼ -32.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $4
Now $24 · 60%
Range high $37
vs 200-day avg +35%
vs 50-day avg +31%
50-day above 200-day golden cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
APLM
this stock
Apollomics Inc.
|
$51.39M | +26.0% | — | — | 0.3% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +17.5% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
15
- % held
- 110.1%
- Net QoQ
- +2.4M sh
- Top holder
- HRT FINANCIAL LP
Held
Float
Short & Settlement
Smart Money
Filings
Earnings & Events
Performance
Raw-price comparisons begin at the captured split on Nov 25, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| APLM | +31.9% | +27.2% | +16.0% | +36.6% | +26.0% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | +31.5% | +22.7% | +2.2% | +32.6% | +12.1% |